Centene Corporation (CNC)
USD 59.62
(2.78%)
USD 59.62
(2.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 636 Million USD | -89.3% |
| 2022 | 5.94 Billion USD | 3.95% |
| 2021 | 5.72 Billion USD | -4.33% |
| 2020 | 5.97 Billion USD | 272.99% |
| 2019 | 1.6 Billion USD | 19.27% |
| 2018 | 1.34 Billion USD | 114.35% |
| 2017 | 627 Million USD | -13.52% |
| 2016 | 725 Million USD | 234.51% |
| 2015 | -539 Million USD | 24.83% |
| 2014 | -717 Million USD | -94.15% |
| 2013 | -369.31 Million USD | -21.05% |
| 2012 | -305.09 Million USD | -37.36% |
| 2011 | -222.12 Million USD | -114.56% |
| 2010 | -103.52 Million USD | -7.81% |
| 2009 | -96.02 Million USD | 15.92% |
| 2008 | -114.2 Million USD | -86.59% |
| 2007 | -61.2 Million USD | 35.86% |
| 2006 | -95.43 Million USD | -73.79% |
| 2005 | -54.91 Million USD | -49.84% |
| 2004 | -36.64 Million USD | 34.74% |
| 2003 | -56.15 Million USD | 5.88% |
| 2002 | -59.65 Million USD | 32.87% |
| 2001 | -88.86 Million USD | -491.54% |
| 2000 | -15.02 Million USD | -475.58% |
| 1999 | 4 Million USD | 0.0% |
| 1998 | 4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 3.02 Billion USD | 13065.22% |
| 2024 Q1 | 415 Million USD | -34.75% |
| 2024 Q2 | 23 Million USD | -94.46% |
| 2023 Q1 | 5.78 Billion USD | -2.66% |
| 2023 FY | 636 Million USD | -89.3% |
| 2023 Q4 | 636 Million USD | -30.64% |
| 2023 Q3 | 917 Million USD | 9.69% |
| 2023 Q2 | 836 Million USD | -85.56% |
| 2022 Q3 | 6.57 Billion USD | -25.2% |
| 2022 Q4 | 5.94 Billion USD | -9.59% |
| 2022 FY | 5.94 Billion USD | 3.95% |
| 2022 Q1 | 11.43 Billion USD | 99.86% |
| 2022 Q2 | 8.79 Billion USD | -23.08% |
| 2021 Q4 | 5.72 Billion USD | 5.61% |
| 2021 Q1 | 8.7 Billion USD | 45.53% |
| 2021 FY | 5.72 Billion USD | -4.33% |
| 2021 Q2 | 5.77 Billion USD | -33.67% |
| 2021 Q3 | 5.41 Billion USD | -6.15% |
| 2020 Q4 | 5.97 Billion USD | 1.94% |
| 2020 FY | 5.97 Billion USD | 272.99% |
| 2020 Q1 | 7.97 Billion USD | 397.26% |
| 2020 Q2 | 4.01 Billion USD | -49.62% |
| 2020 Q3 | 5.86 Billion USD | 46.04% |
| 2019 Q2 | 259 Million USD | -44.89% |
| 2019 Q4 | 1.6 Billion USD | 94.07% |
| 2019 FY | 1.6 Billion USD | 19.27% |
| 2019 Q3 | 826 Million USD | 218.92% |
| 2019 Q1 | 470 Million USD | -65.03% |
| 2018 Q2 | -428 Million USD | 13.01% |
| 2018 FY | 1.34 Billion USD | 114.35% |
| 2018 Q4 | 1.34 Billion USD | 389.66% |
| 2018 Q3 | -464 Million USD | -8.41% |
| 2018 Q1 | -492 Million USD | -178.47% |
| 2017 Q1 | -192 Million USD | -126.48% |
| 2017 FY | 627 Million USD | -13.52% |
| 2017 Q4 | 627 Million USD | 42.5% |
| 2017 Q3 | 440 Million USD | 49.15% |
| 2017 Q2 | 295 Million USD | 253.65% |
| 2016 FY | 725 Million USD | 234.51% |
| 2016 Q3 | 1.6 Billion USD | -9.92% |
| 2016 Q1 | 844 Million USD | 256.59% |
| 2016 Q4 | 725 Million USD | -54.88% |
| 2016 Q2 | 1.78 Billion USD | 111.37% |
| 2015 Q4 | -539 Million USD | -40.36% |
| 2015 Q3 | -384 Million USD | 53.34% |
| 2015 FY | -539 Million USD | 24.83% |
| 2015 Q2 | -823 Million USD | -52.97% |
| 2015 Q1 | -538 Million USD | 24.97% |
| 2014 FY | -717 Million USD | -94.15% |
| 2014 Q2 | -367.77 Million USD | 18.94% |
| 2014 Q3 | -628.12 Million USD | -70.79% |
| 2014 Q4 | -717 Million USD | -14.15% |
| 2014 Q1 | -453.71 Million USD | -22.85% |
| 2013 FY | -369.31 Million USD | -21.05% |
| 2013 Q4 | -369.31 Million USD | -67.64% |
| 2013 Q3 | -220.3 Million USD | -60.56% |
| 2013 Q2 | -137.21 Million USD | 29.51% |
| 2013 Q1 | -194.63 Million USD | 36.2% |
| 2012 Q3 | -401.31 Million USD | -2956.44% |
| 2012 FY | -305.09 Million USD | -37.36% |
| 2012 Q4 | -305.09 Million USD | 23.97% |
| 2012 Q1 | -82.6 Million USD | 62.81% |
| 2012 Q2 | -13.13 Million USD | 84.1% |
| 2011 Q3 | -100.36 Million USD | 25.55% |
| 2011 Q1 | -186.68 Million USD | -80.33% |
| 2011 Q2 | -134.81 Million USD | 27.79% |
| 2011 FY | -222.12 Million USD | -114.56% |
| 2011 Q4 | -222.12 Million USD | -121.32% |
| 2010 Q4 | -103.52 Million USD | 22.45% |
| 2010 FY | -103.52 Million USD | -7.81% |
| 2010 Q2 | 442.57 Million USD | 35.15% |
| 2010 Q1 | 327.46 Million USD | 441.03% |
| 2010 Q3 | -133.49 Million USD | -130.16% |
| 2009 Q1 | 320.61 Million USD | 380.73% |
| 2009 Q2 | 299.04 Million USD | -6.73% |
| 2009 Q3 | -116.65 Million USD | -139.01% |
| 2009 Q4 | -96.02 Million USD | 17.68% |
| 2009 FY | -96.02 Million USD | 15.92% |
| 2008 Q3 | -25.31 Million USD | 81.31% |
| 2008 Q4 | -114.2 Million USD | -351.21% |
| 2008 Q2 | -135.39 Million USD | -184.76% |
| 2008 Q1 | -47.54 Million USD | 22.32% |
| 2008 FY | -114.2 Million USD | -86.59% |
| 2007 Q4 | -61.2 Million USD | 16.05% |
| 2007 FY | -61.2 Million USD | 35.86% |
| 2007 Q3 | -72.91 Million USD | -106.49% |
| 2007 Q2 | -35.3 Million USD | 68.06% |
| 2007 Q1 | -110.53 Million USD | -15.83% |
| 2006 Q2 | 34.06 Million USD | 140.88% |
| 2006 Q1 | 14.14 Million USD | 125.75% |
| 2006 FY | -95.43 Million USD | -73.79% |
| 2006 Q4 | -95.43 Million USD | -207.65% |
| 2006 Q3 | -31.01 Million USD | -191.07% |
| 2005 FY | -54.91 Million USD | -49.84% |
| 2005 Q1 | -59.93 Million USD | -63.56% |
| 2005 Q4 | -54.91 Million USD | -64.95% |
| 2005 Q3 | -33.28 Million USD | -168.86% |
| 2005 Q2 | -12.38 Million USD | 79.34% |
| 2004 Q2 | -72.71 Million USD | -99.06% |
| 2004 Q4 | -36.64 Million USD | 54.76% |
| 2004 Q3 | -80.99 Million USD | -11.39% |
| 2004 FY | -36.64 Million USD | 34.74% |
| 2004 Q1 | -36.53 Million USD | 34.94% |
| 2003 Q4 | -56.15 Million USD | -3.32% |
| 2003 Q2 | -43.42 Million USD | 27.59% |
| 2003 FY | -56.15 Million USD | 5.88% |
| 2003 Q1 | -59.97 Million USD | -0.53% |
| 2003 Q3 | -54.34 Million USD | -25.16% |
| 2002 Q1 | -91.73 Million USD | 0.0% |
| 2002 Q3 | -56.06 Million USD | -26.46% |
| 2002 Q4 | -59.65 Million USD | -6.4% |
| 2002 Q2 | -44.33 Million USD | 51.67% |
| 2002 FY | -59.65 Million USD | 32.87% |
| 2001 FY | -88.86 Million USD | -491.54% |
| 2000 FY | -15.02 Million USD | -475.58% |
| 1999 FY | 4 Million USD | 0.0% |
| 1998 FY | 4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cigna Corporation | 23.65 Billion USD | 97.312% |
| CVS Health Corporation | 71.18 Billion USD | 99.107% |
| Elevance Health Inc. | 18.59 Billion USD | 96.58% |
| Humana Inc. | 7.57 Billion USD | 91.604% |
| Molina Healthcare, Inc. | -2.46 Billion USD | 125.822% |
| Oscar Health, Inc. | -1.57 Billion USD | 140.47% |
| UnitedHealth Group Incorporated | 42 Billion USD | 98.486% |